A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells

[1]  A. Schmidtchen,et al.  Injury is a major inducer of epidermal innate immune responses during wound healing. , 2010, Journal of Investigative Dermatology.

[2]  A. Büchau.  EGFR (trans)activation mediates IL-8 and distinct human antimicrobial peptide and protein production following skin injury. , 2010, The Journal of investigative dermatology.

[3]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[4]  A. Tsatsakis,et al.  Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells , 2008, Molecular Cancer Research.

[5]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[6]  G. Tzanakakis,et al.  Decorin-Mediated Effects in Cancer Cell Biology , 2008, Connective tissue research.

[7]  M. Hung,et al.  Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family* , 2007, Journal of Biological Chemistry.

[8]  R. Iozzo,et al.  Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 Activation* , 2006, Journal of Biological Chemistry.

[9]  Jennifer L Hunt,et al.  Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting , 2006, Clinical Cancer Research.

[10]  E. Lillehoj,et al.  Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[11]  M. Hung,et al.  EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization , 2006, Breast Cancer Research and Treatment.

[12]  M. Hung,et al.  Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival , 2006, British Journal of Cancer.

[13]  M. Daha,et al.  Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins1 , 2005, The Journal of Immunology.

[14]  Charles C. Reed,et al.  Decorin Evokes Protracted Internalization and Degradation of the Epidermal Growth Factor Receptor via Caveolar Endocytosis* , 2005, Journal of Biological Chemistry.

[15]  D. Rimm,et al.  Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis , 2005, Clinical Cancer Research.

[16]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[17]  M. Hung,et al.  Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. , 2004, Cancer cell.

[18]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[19]  J. Vishwanatha,et al.  Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. , 2003, Cancer research.

[20]  James S. Brown,et al.  Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. , 2003, Oral oncology.

[21]  H. Watanabe,et al.  Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. , 2002, Oral oncology.

[22]  R. Iozzo,et al.  Decorin Binds to a Narrow Region of the Epidermal Growth Factor (EGF) Receptor, Partially Overlapping but Distinct from the EGF-binding Epitope* , 2002, The Journal of Biological Chemistry.

[23]  X. F. Wang,et al.  Transforming growth factor β1 dysregulation in a human oral carcinoma tumour progression model , 2002, Cell proliferation.

[24]  Ming You,et al.  Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  B. Kobe,et al.  The leucine-rich repeat as a protein recognition motif. , 2001, Current opinion in structural biology.

[26]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[27]  G. Mills,et al.  Genetic analysis of early- versus late-stage ovarian tumors. , 2001, Cancer research.

[28]  C. Ruchti,et al.  Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. , 2001, Thyroid : official journal of the American Thyroid Association.

[29]  I. Fidler,et al.  Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Y. Sakao,et al.  α-Chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for α-chemokines inhibits the growth of adenocarcinoma cell lines , 2000, Journal of Cancer Research and Clinical Oncology.

[32]  J. Reiland,et al.  CXC‐chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor , 1999, The Prostate.

[33]  R. Iozzo.  The Biology of the Small Leucine-rich Proteoglycans , 1999, The Journal of Biological Chemistry.

[34]  M. Burdick,et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.

[35]  R. Iozzo,et al.  Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[36]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[37]  T. Shinomura,et al.  Leucine-rich repeat glycoproteins of the extracellular matrix. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[38]  J. Gershenwald,et al.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. , 1997, The American journal of pathology.

[39]  R. Rees,et al.  Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.

[40]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[41]  R. Iozzo,et al.  Altered proteoglycan gene expression and the tumor stroma , 1993, Experientia.

[42]  P. Chambon,et al.  Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. , 1991, Cancer research.

[43]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[44]  Michael J Thun,et al.  Cancer occurrence. , 2009, Methods in molecular biology.

[45]  Lajos Döbróssy,et al.  Epidemiology of head and neck cancer: Magnitude of the problem , 2005, Cancer and Metastasis Reviews.

[46]  Peter H Watson,et al.  Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  S. Christmas,et al.  Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. , 2000, Cytokine.